Study: DOCK8 mutation disrupts helper T cell differentiation via glycolytic pathway regulation
A study, published in the journal MedComm and led by Dr. Panpan Jiang and collaborators at Tongji Medical College, explores ...
EurekAlert!5 天
One million Euro funding - developmental biologist receives NOMIS grant
How do we develop from a single cell to a multicellular organism with a gut, heart, and brain? What are the forces initiating life? Carl-Philipp Heisenberg, professor at the Institute of Science and ...
EurekAlert!7 天
DOCK8 mutation disrupts helper T cell differentiation via glycolytic pathway regulation
Recent research published in MedComm highlights how mutations in the Dedicator of Cytokinesis 8 (DOCK8) gene impair the differentiation of helper T cells by affecting their glycolytic metabolism. This ...
Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market
Discover Cardiff Oncology's promising results with Onvansertib for RAS-mutated colorectal cancer, potentially leading to ...
Pharmaceutical Technology13 天
Bcl 2 Like Protein 1 drugs in development, 2024
GlobalData’s report assesses the drugs in the Bcl 2 Like Protein 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
Pharmaceutical Technology1 个月
Aurora Kinase B drugs in development, 2024
GlobalData’s report assesses the drugs in the Aurora Kinase B pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
DelveInsight Business Research, LLP: PLK-1 Inhibitors Market to Register Immense Growth by ...
The PLK-1 inhibitors market is experiencing robust growth driven by increasing investments in cancer research and the expanding pipeline of novel therapeutic agents. The rising prevalence of ...